Achieve Life Sciences, Inc. (FRA:SP4P)

Germany flag Germany · Delayed Price · Currency is EUR
4.605
+0.235 (5.38%)
At close: Jan 9, 2026
29.90%
Market Cap254.45M
Revenue (ttm)n/a
Net Income (ttm)-44.61M
Shares Outn/a
EPS (ttm)-1.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume15
Open4.605
Previous Close4.370
Day's Range4.605 - 4.605
52-Week Range1.732 - 4.605
Betan/a
RSI67.20
Earnings DateMar 13, 2026

About Achieve Life Sciences

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington. [Read more]

Industry Pharmaceutical Preparations
CEO Richard A. Stewart
Employees 25
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol SP4P
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.